Article
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.
Blood - 15 Jul 1990
Vose J M, Peterson C, Bierman P J, Weisenburger D D, Linder J, Harrington D, Vaughan W P, Kessinger A, Armitage J O
Abstract excerpt
Advanced T-cell non-Hodgkin's lymphoma in adults has been found to have a poor outlook with conventional chemotherapy. To see if this extends to patients treated with high dose therapy and autologous hematopoietic stem cell transplantation, we reviewed the results with this treatment approach at...
Topics
- Adolescent
- Adult
- Antigens, Surface
- Antineoplastic Agents
- B-Lymphocytes
- Bone Marrow Transplantation
- Combined Modality Therapy
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Lymphoma, Non-Hodgkin
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Phenotype
- Prognosis
- T-Lymphocytes
- Transplantation, Autologous